{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:59:19Z","timestamp":1790747959290,"version":"4.1.0"},"reference-count":30,"publisher":"American Society for Microbiology","issue":"11","license":[{"start":{"date-parts":[[2001,6,1]],"date-time":"2001-06-01T00:00:00Z","timestamp":991353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Virol"],"published-print":{"date-parts":[[2001,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>CD8 T cells drive the protective immune response to lymphocytic choriomeningitis virus (LCMV) infection and are thus a determining force in the selection of viral variants. To examine how escape mutations affect the presentation and recognition of overlapping T-cell epitopes, we isolated an LCMV variant that is not recognized by T-cell receptor (TCR)-transgenic H-2D<jats:sup>b<\/jats:sup>-restricted LCMV GP33-41-specific cytotoxic T lymphocytes (CTL). The variant virus carried a single-amino-acid substitution (valine to alanine) at position 35 of the viral glycoprotein. This region of the LCMV glycoprotein encodes both the D<jats:sup>b<\/jats:sup>-restricted GP33-43 epitope and a second epitope (GP34-42) presented by the K<jats:sup>b<\/jats:sup>molecule. We determined that the V-to-A CTL escape mutant failed to induce a D<jats:sup>b<\/jats:sup>GP33-43-specific CTL response and that D<jats:sup>b<\/jats:sup>-restricted GP33-43-specific CTL induced by the wild-type LCMV strain were unable to kill target cells infected with the variant LCMV strain. In contrast, the K<jats:sup>b<\/jats:sup>-restricted response was much less affected. We found that the V-to-A substitution severely impaired peptide binding to D<jats:sup>b<\/jats:sup>but not to K<jats:sup>b<\/jats:sup>molecules. Strikingly, the V-to-A mutation did not change any of the anchor residues, and the dramatic effect on binding was therefore unexpected. The strong decrease in D<jats:sup>b<\/jats:sup>binding explains why the variant virus escapes the D<jats:sup>b<\/jats:sup>GP33-43-specific response but still elicits the K<jats:sup>b<\/jats:sup>-restricted response. These findings also illustrate that mutations within regions encoding overlapping T-cell epitopes can differentially affect the presentation and recognition of individual epitopes.<\/jats:p>","DOI":"10.1128\/jvi.75.11.5099-5107.2001","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T10:06:37Z","timestamp":1027764397000},"page":"5099-5107","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":52,"title":["In Vivo Selection of a Lymphocytic Choriomeningitis Virus Variant That Affects Recognition of the GP33-43 Epitope by H-2D<sup>b<\/sup>but Not H-2K<sup>b<\/sup>"],"prefix":"10.1128","volume":"75","author":[{"given":"Maryann T.","family":"Puglielli","sequence":"first","affiliation":[{"name":"<!--label omitted: 1-->Emory Vaccine Center and Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia 30322,1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan J.","family":"Zajac","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Emory Vaccine Center and Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia 30322,1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robbert G.","family":"van der Most","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Emory Vaccine Center and Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia 30322,1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John L.","family":"Dzuris","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->Epimmune, Inc., San Diego, California 92121, and Department of Analytical Sciences and Immunological Diseases, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 068772"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Sette","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->Epimmune, Inc., San Diego, California 92121, and Department of Analytical Sciences and Immunological Diseases, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 068772"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Altman","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Emory Vaccine Center and Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia 30322,1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafi","family":"Ahmed","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Emory Vaccine Center and Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia 30322,1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.160.2.521"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-5699(00)01699-6"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/35030124"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.274.5284.94"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.71.8.5764-5768.1997"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.180.3.933"},{"key":"e_1_3_2_8_2","unstructured":"Buchmeier M. J. Zajac A. J. Lymphocytic choriomeningitis virus Persistent viral infections. Ahmed R. Chen I. S. Y. 1999 575 606 John Wiley and Sons New York N.Y"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.7682013"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.69.4.2297-2305.1995"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.187.10.1647-b"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1997.8627"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/28860"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1995.1314"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.68.12.8056-8063.1994"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.69.4.2187-2193.1995"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80470-7"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1521-4141(199904)29:04<1243::AID-IMMU1243>3.0.CO;2-A"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/354453a0"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/342559a0"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/346629a0"},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","unstructured":"Puglielli M. T. Ahmed R. Persistent viral infection Encyclopedia of virology 2nd ed. Webster R. G. Granoff A. 1999 1200 1205 Academic Press London U.K","DOI":"10.1006\/rwvi.1999.0217"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00172063"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0161-5890(94)90019-1"},{"key":"e_1_3_2_25_2","doi-asserted-by":"crossref","first-page":"5586","DOI":"10.4049\/jimmunol.153.12.5586","article-title":"The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes","volume":"153","author":"Sette A.","year":"1994","unstructured":"Sette A. Vitiello A. Reherman B. Fowler P. Nayersina R. Kast W. M. Melief C. J. M. Oseroff C. Yuan L. Ruppert J. Sidney J. Del Guercio M.-F. Southwood S. Kubo R. T. Chesnut R. W. Grey H. M. Chisari F. V. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes.J. Immunol. 153 1994 5586 5592","journal-title":"J. Immunol."},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.188.1.71"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1006\/jmbi.2000.4501"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1997.8934"},{"key":"e_1_3_2_29_2","doi-asserted-by":"crossref","first-page":"5555","DOI":"10.4049\/jimmunol.157.12.5555","article-title":"Immunodominance analysis of CTL responses to influenza PR8 virus reveals two new dominant and subdominant Kb-restricted epitopes","volume":"157","author":"Vitiello A.","year":"1996","unstructured":"Vitiello A. Yuan L. Chesnut R. W. Sidney J. Southwood S. Farness P. Jackson M. R. Peterson P. A. Sette A. Immunodominance analysis of CTL responses to influenza PR8 virus reveals two new dominant and subdominant Kb-restricted epitopes.J. Immunol. 157 1996 5555 5562","journal-title":"J. Immunol."},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.69.11.7147-7151.1995"},{"key":"e_1_3_2_31_2","doi-asserted-by":"crossref","first-page":"5526","DOI":"10.4049\/jimmunol.163.10.5526","article-title":"Impaired anti-viral T cell responses due to expression of the Ly49A inhibitory receptor","volume":"163","author":"Zajac A. J.","year":"1999","unstructured":"Zajac A. J. Vance R. E. Held W. Sourdive D. J. Altman J. D. Raulet D. H. Ahmed R. Impaired anti-viral T cell responses due to expression of the Ly49A inhibitory receptor.J. Immunol. 163 1999 5526 5534","journal-title":"J. Immunol."}],"container-title":["Journal of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.75.11.5099-5107.2001","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.75.11.5099-5107.2001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,23]],"date-time":"2023-04-23T15:51:17Z","timestamp":1682265077000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JVI.75.11.5099-5107.2001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,6]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2001,6]]}},"alternative-id":["10.1128\/JVI.75.11.5099-5107.2001"],"URL":"https:\/\/doi.org\/10.1128\/jvi.75.11.5099-5107.2001","relation":{},"ISSN":["0022-538X","1098-5514"],"issn-type":[{"value":"0022-538X","type":"print"},{"value":"1098-5514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,6]]},"assertion":[{"value":"1999-10-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2001-03-06","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2001-06-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}